Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical
company focused on developing and commercializing a portfolio of
products for the critical care market, today announced that the Company
received shareholder approval to change the Company name to Tenax
Therapeutics, Inc. The name change shall go into effect on Friday,
September 19, 2014, and at market open the Company’s common stock will
trade on the NASDAQ Capital Market under its new ticker symbol “TENX”.
The new CUSIP number for the common stock is 88032L 100 following the
name and ticker change.
Inc. (OTC Pink: IRCED) today announces that the previously filed
Company-Related Action Notification for a corporate name change and
5-for-1 forward split was made effective by the Financial Industry
Regulatory Authority (FINRA) on December 3.
Kerry Phelan Named Lionsgate Executive Vice President of Global Franchise Management and Strategic Partnerships 25-Year Industry Veteran Played Key Role in Growing LEGO, Star Wars and DreamWorks Brands Canada NewsWire
SANTA MONICA, Calif.
Air Canada Named Canada's Preferred Airline by Frequent Canadian Business Travellers in Ipsos Reid Study Canada NewsWire
Air Canada's Margin Relative to Domestic Competitors Continues to Widen MONTREAL , Sept.
FOREST CITY, IA--(Marketwired - October 06, 2014) - Winnebago Industries, Inc. (NYSE: WGO), has been named to the Barron's 400 Index in its bi-annual rebalance in September.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.